CCN2 and carcinoid heart disease: Although several non-invasive biomarkers have been investigated in the context of carcinoid heart disease [1], only a few studies have assessed the utility of non-invasive biomarkers (serum CTGF [Connective Tissue Growth Factor], urinary 5-HIAA [5-hydroxyindoleacetic acid]) in MF [3, 8, 9].